Just a reminder that FXCRC sites are participating in Neuren's Fragile X trials. I'm guessing Neuren's trial may get a mention. If we are lucky.
"Neuren Pharmaceuticals (NEU) has received approval from the US Food and Drug Administration to conduct a Phase 2 clinical trial of a drug to treat patients with fragile X syndrome (FXS), the company recently announced. The trial is expected to start before the end of 2013, and is expected to involve several sites within the Fragile X Clinical & Research Consortium (FXCRC). - See more at: http://www.fragilex.org/2013/resear...-for-fragile-x-syndrome/#sthash.mQWV3nzc.dpuf"
- Forums
- ASX - By Stock
- NEU
- Fragile X
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.75%
!
$14.48

Fragile X, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.48 |
Change
-0.110(0.75%) |
Mkt cap ! $1.773B |
Open | High | Low | Value | Volume |
$14.36 | $14.51 | $14.25 | $1.004M | 69.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30 | $14.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.51 | 201 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 46 | 14.490 |
2 | 4 | 14.480 |
2 | 322 | 14.470 |
5 | 653 | 14.460 |
5 | 1114 | 14.450 |
Price($) | Vol. | No. |
---|---|---|
14.510 | 201 | 3 |
14.520 | 433 | 5 |
14.530 | 647 | 5 |
14.540 | 1264 | 7 |
14.550 | 453 | 4 |
Last trade - 11.17am 16/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online